Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

Anaemia in inflammatory bowel disease: a population-based 10-year follow-up.

Høivik ML, Reinisch W, Cvancarova M, Moum B; IBSEN study group.

Aliment Pharmacol Ther. 2014 Jan;39(1):69-76. doi: 10.1111/apt.12541. Epub 2013 Oct 31.

PMID:
24172277
[PubMed - indexed for MEDLINE]
2.

Mortality and causes of death in Crohn's disease: results from 20 years of follow-up in the IBSEN study.

Hovde Ø, Kempski-Monstad I, Småstuen MC, Solberg IC, Henriksen M, Jahnsen J, Stray N, Moum BA.

Gut. 2014 May;63(5):771-5. doi: 10.1136/gutjnl-2013-304766. Epub 2013 Jun 6.

PMID:
23744613
[PubMed - indexed for MEDLINE]
3.

[Pain in connection with colonoscopy in Norway].

Holme Ø, Moritz V, Bretthauer M, Seip B, Glomsaker T, de Lange T, Aabakken L, Stallemo A, Høie O, Dahler S, Sandvei PK, Stray N, Ystrøm CM, Hoff G.

Tidsskr Nor Laegeforen. 2013 May 28;133(10):1074-8. doi: 10.4045/tidsskr.12.1467. Norwegian.

PMID:
23712171
[PubMed - indexed for MEDLINE]
Free Article
4.

A young woman with upper gastrointestinal bleeding.

Sarna VK, Stray N.

Tidsskr Nor Laegeforen. 2012 Oct 2;132(18):2070-2. doi: 10.4045/tidsskr.11.1197. English, Norwegian. No abstract available.

PMID:
23038199
[PubMed - indexed for MEDLINE]
Free Article
5.

Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study.

Høivik ML, Moum B, Solberg IC, Henriksen M, Cvancarova M, Bernklev T; IBSEN Group.

Gut. 2013 Mar;62(3):368-75. doi: 10.1136/gutjnl-2012-302311. Epub 2012 Jun 20.

PMID:
22717453
[PubMed - indexed for MEDLINE]
6.

Patients with Crohn's disease experience reduced general health and vitality in the chronic stage: ten-year results from the IBSEN study.

Høivik ML, Bernklev T, Solberg IC, Cvancarova M, Lygren I, Jahnsen J, Moum B; IBSEN Study Group.

J Crohns Colitis. 2012 May;6(4):441-53. doi: 10.1016/j.crohns.2011.10.001. Epub 2011 Nov 9.

PMID:
22398064
[PubMed - indexed for MEDLINE]
Free Article
7.

Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data.

Schreiber S, Colombel JF, Bloomfield R, Nikolaus S, Schölmerich J, Panés J, Sandborn WJ; PRECiSE 2 Study Investigators.

Am J Gastroenterol. 2010 Jul;105(7):1574-82. doi: 10.1038/ajg.2010.78. Epub 2010 Mar 16.

PMID:
20234346
[PubMed - indexed for MEDLINE]
8.

Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 months.

Lichtenstein GR, Thomsen OØ, Schreiber S, Lawrance IC, Hanauer SB, Bloomfield R, Sandborn WJ; Precise 3 Study Investigators.

Clin Gastroenterol Hepatol. 2010 Jul;8(7):600-9. doi: 10.1016/j.cgh.2010.01.014. Epub 2010 Feb 1.

PMID:
20117244
[PubMed - indexed for MEDLINE]
9.

Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).

Solberg IC, Lygren I, Jahnsen J, Aadland E, Høie O, Cvancarova M, Bernklev T, Henriksen M, Sauar J, Vatn MH, Moum B; IBSEN Study Group.

Scand J Gastroenterol. 2009;44(4):431-40. doi: 10.1080/00365520802600961.

PMID:
19101844
[PubMed - indexed for MEDLINE]
10.

Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease.

Solberg IC, Lygren I, Cvancarova M, Jahnsen J, Stray N, Sauar J, Schreiber S, Moum B, Vatn MH; IBSEN Study Group.

Inflamm Bowel Dis. 2009 Mar;15(3):406-14. doi: 10.1002/ibd.20781.

PMID:
19009607
[PubMed - indexed for MEDLINE]
11.

Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility.

Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G, Domingues FS, Albrecht M, Nothnagel M, Ellinghaus D, Sina C, Onnie CM, Weersma RK, Stokkers PC, Wijmenga C, Gazouli M, Strachan D, McArdle WL, Vermeire S, Rutgeerts P, Rosenstiel P, Krawczak M, Vatn MH; IBSEN study group, Mathew CG, Schreiber S.

Nat Genet. 2008 Nov;40(11):1319-23. doi: 10.1038/ng.221. Epub 2008 Oct 5.

PMID:
18836448
[PubMed - indexed for MEDLINE]
12.

The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in southeastern Norway.

Aamodt G, Bukholm G, Jahnsen J, Moum B, Vatn MH; IBSEN Study Group.

Am J Epidemiol. 2008 Nov 1;168(9):1065-72. doi: 10.1093/aje/kwn218. Epub 2008 Sep 18.

PMID:
18801890
[PubMed - indexed for MEDLINE]
Free Article
13.

C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.

Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B; IBSEN Study Group.

Gut. 2008 Nov;57(11):1518-23. doi: 10.1136/gut.2007.146357. Epub 2008 Jun 19.

PMID:
18566104
[PubMed - indexed for MEDLINE]
14.

Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study.

Solberg IC, Vatn MH, Høie O, Stray N, Sauar J, Jahnsen J, Moum B, Lygren I; IBSEN Study Group.

Clin Gastroenterol Hepatol. 2007 Dec;5(12):1430-8.

PMID:
18054751
[PubMed - indexed for MEDLINE]
15.

Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).

Henriksen M, Jahnsen J, Lygren I, Sauar J, Schulz T, Stray N, Vatn MH, Moum B; Ibsen Study Group.

Scand J Gastroenterol. 2006 Sep;41(9):1037-43.

PMID:
16938716
[PubMed - indexed for MEDLINE]
16.

A prospective study of same day bi-directional endoscopy in the evaluation of patients with occult gastrointestinal bleeding.

Stray N, Weberg R.

Scand J Gastroenterol. 2006 Jul;41(7):844-50.

PMID:
16785199
[PubMed - indexed for MEDLINE]
17.

Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease.

Bernklev T, Jahnsen J, Henriksen M, Lygren I, Aadland E, Sauar J, Schulz T, Stray N, Vatn M, Moum B.

Inflamm Bowel Dis. 2006 May;12(5):402-12.

PMID:
16670530
[PubMed - indexed for MEDLINE]
18.

Course of disease, drug treatment and health-related quality of life in patients with inflammatory bowel disease 5 years after initial diagnosis.

Bernklev T, Jahnsen J, Schulz T, Sauar J, Lygren I, Henriksen M, Stray N, Kjellevold Ø, Aadland E, Vatn M, Moum B.

Eur J Gastroenterol Hepatol. 2005 Oct;17(10):1037-45.

PMID:
16148548
[PubMed - indexed for MEDLINE]
19.

Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis.

Bernklev T, Jahnsen J, Aadland E, Sauar J, Schulz T, Lygren I, Henriksen M, Stray N, Kjellevold O, Vatn M, Moum B; IBSEN Study Group.

Scand J Gastroenterol. 2004 Apr;39(4):365-73.

PMID:
15125469
[PubMed - indexed for MEDLINE]
20.

Screening of first degree relatives of patients operated for colorectal cancer: evaluation of fecal calprotectin vs. hemoccult II.

Kristinsson J, Nygaard K, Aadland E, Barstad S, Sauar J, Hofstad B, Stray N, Stallemo A, Haug B, Ugstad M, Tøn H, Fuglerud P.

Digestion. 2001;64(2):104-10.

PMID:
11684824
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk